Fosamprenavir how supplied: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
 
Line 7: Line 7:
* LEXIVA Tablets, 700 mg, are pink, film-coated, capsule-shaped, biconvex tablets, with “GX LL7” debossed on one face.
* LEXIVA Tablets, 700 mg, are pink, film-coated, capsule-shaped, biconvex tablets, with “GX LL7” debossed on one face.


Bottle of 60 with child-resistant closure (NDC 49702-207-18).
: Bottle of 60 with child-resistant closure (NDC 49702-207-18).


Store at controlled room temperature of 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) . Keep container tightly closed.
: Store at controlled room temperature of 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) . Keep container tightly closed.


* LEXIVA Oral Suspension, a white to off-white grape-bubblegum-peppermint–flavored suspension, contains 50 mg of fosamprenavir as fosamprenavir calcium equivalent to approximately 43 mg of amprenavir in each 1 mL.
* LEXIVA Oral Suspension, a white to off-white grape-bubblegum-peppermint–flavored suspension, contains 50 mg of fosamprenavir as fosamprenavir calcium equivalent to approximately 43 mg of amprenavir in each 1 mL.


Bottle of 225 mL with child-resistant closure (NDC 49702-208-53).
: Bottle of 225 mL with child-resistant closure (NDC 49702-208-53).


This product does not require reconstitution.
: This product does not require reconstitution.


Store in refrigerator or at room temperature (5° to 30°C; 41° to 86°F). Shake vigorously before using.
: Store in refrigerator or at room temperature (5° to 30°C; 41° to 86°F). Shake vigorously before using.


Do not freeze.<ref>{{Cite web  | last =  | first =  | title = LEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED LEXIVA (FOSAMPRENAVIR CALCIUM) SUSPENSION [VIIV HEALTHCARE COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24feb9be-32a6-45fd-a896-f3e202edd8a9 | publisher =  | date =  | accessdate =  }}</ref>
: Do not freeze.<ref>{{Cite web  | last =  | first =  | title = LEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED LEXIVA (FOSAMPRENAVIR CALCIUM) SUSPENSION [VIIV HEALTHCARE COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24feb9be-32a6-45fd-a896-f3e202edd8a9 | publisher =  | date =  | accessdate =  }}</ref>


==References==
==References==

Latest revision as of 19:25, 5 January 2014

Fosamprenavir
LEXIVA® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

How Supplied/Storage and Handling

  • LEXIVA Tablets, 700 mg, are pink, film-coated, capsule-shaped, biconvex tablets, with “GX LL7” debossed on one face.
Bottle of 60 with child-resistant closure (NDC 49702-207-18).
Store at controlled room temperature of 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) . Keep container tightly closed.
  • LEXIVA Oral Suspension, a white to off-white grape-bubblegum-peppermint–flavored suspension, contains 50 mg of fosamprenavir as fosamprenavir calcium equivalent to approximately 43 mg of amprenavir in each 1 mL.
Bottle of 225 mL with child-resistant closure (NDC 49702-208-53).
This product does not require reconstitution.
Store in refrigerator or at room temperature (5° to 30°C; 41° to 86°F). Shake vigorously before using.
Do not freeze.[1]

References

  1. "LEXIVA (FOSAMPRENAVIR CALCIUM) TABLET, FILM COATED LEXIVA (FOSAMPRENAVIR CALCIUM) SUSPENSION [VIIV HEALTHCARE COMPANY]".

Adapted from the FDA Package Insert.